CFTR c.791A>T ;(p.E264V)

Variant ID: 7-117176649-A-T

NM_000492.3(CFTR):c.791A>T;(p.E264V)

This variant was identified in 9 publications

View GRCh38 version.




Publications:


Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases.

Cells
Bisserier, Malik M; Sun, Xiao-Qing XQ; Fazal, Shahood S; Turnbull, Irene C IC; Bonnet, Sébastien S; Hadri, Lahouaria L
Publication Date: 2022-03-12

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 35326434
Variant Present in the following documents:
  • Main text
  • cells-11-00984.pdf
View BVdb publication page



Abstracts from the Irish Thoracic Society Annual Scientific Meeting 2021.

Irish Journal Of Medical Science
Publication Date: 2021-12

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 34904212
Variant Present in the following documents:
  • Main text
  • 11845_2021_Article_2845.pdf
View BVdb publication page



Abstracts from the Irish Thoracic Society Annual Scientific Meeting 2021.

Irish Journal Of Medical Science
Publication Date: 2021-12

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 34904212
Variant Present in the following documents:
  • Main text
  • 11845_2021_Article_2845.pdf
View BVdb publication page



Update on Alpha-1 Antitrypsin Deficiency in Liver Disease.

Clinical Liver Disease
Narayanan, Praveena P; Mistry, Pramod K PK
Publication Date: 2020-06

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 32617155
Variant Present in the following documents:
  • Main text
View BVdb publication page



The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Journal Of Inflammation Research
Dunlea, Danielle M DM; Fee, Laura T LT; McEnery, Thomas T; McElvaney, Noel G NG; Reeves, Emer P EP
Publication Date: 2018

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 29618937
Variant Present in the following documents:
  • Main text
  • jir-11-123.pdf
View BVdb publication page



Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.

Bmc Medical Genomics
Gal, Moran M; Khermesh, Khen K; Barak, Michal M; Lin, Min M; Lahat, Hadas H; Reznik Wolf, Haike H; Lin, Michael M; Pras, Elon E; Levanon, Erez Y EY
Publication Date: 2016-05-13

Variant appearance in text: CFTR: E264V
PubMed Link: 27175728
Variant Present in the following documents:
  • Main text
View BVdb publication page



Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency.

Plos One
Cummings, Erin E EE; O'Reilly, Linda P LP; King, Dale E DE; Silverman, Richard M RM; Miedel, Mark T MT; Luke, Cliff J CJ; Perlmutter, David H DH; Silverman, Gary A GA; Pak, Stephen C SC
Publication Date: 2015

Variant appearance in text: CFTR: E264V
PubMed Link: 26512890
Variant Present in the following documents:
  • Main text
  • pone.0141542.pdf
View BVdb publication page



The tumor necrosis factor α (-308 A/G) polymorphism is associated with cystic fibrosis in Mexican patients.

Plos One
Sanchez-Dominguez, Celia N CN; Reyes-Lopez, Miguel A MA; Bustamante, Adriana A; Cerda-Flores, Ricardo M RM; Villalobos-Torres, Maria Del C Mdel C; Gallardo-Blanco, Hugo L HL; Rojas-Martinez, Augusto A; Martinez-Rodriguez, Herminia G HG; Barrera-Saldaña, Hugo A HA; Ortiz-Lopez, Rocio R
Publication Date: 2014

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 24603877
Variant Present in the following documents:
  • Main text
  • pone.0090945.pdf
View BVdb publication page



Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.

The Journal Of Biological Chemistry
Bouchecareilh, Marion M; Hutt, Darren M DM; Szajner, Patricia P; Flotte, Terence R TR; Balch, William E WE
Publication Date: 2012-11-02

Variant appearance in text: CFTR: E264V
PubMed Link: 22995909
Variant Present in the following documents:
  • Main text
View BVdb publication page



Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.

Biologics : Targets & Therapy
McLean, Caitriona C; Greene, Catherine M CM; McElvaney, Noel G NG
Publication Date: 2009

Variant appearance in text: CFTR: Glu264Val
PubMed Link: 19707397
Variant Present in the following documents:
  • btt-3-063.pdf
View BVdb publication page